<DOC>
	<DOC>NCT00380588</DOC>
	<brief_summary>To investigate efficacy and safety of gemcitabine combined with cisplatin and of gemcitabine alone by comparison in patients with advanced biliary tract cancer</brief_summary>
	<brief_title>Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histological or cytological diagnosis of biliary tract cancer Measurable disease must be at least one lesion Chemotherapyna√Øve Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 Estimated life expectancy no less than 3 months radiological or clinical evidence of pulmonary fibrosis or interstitial pneumonia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>